Alkapress Trio 5/160/25 mg 14 tablets
Hikma Pharmaceuticals
Hikma Pharmaceuticals
Overview
Alkapress Trio is a fixed-dose triple-combination tablet containing amlodipine, valsartan and hydrochlorothiazide, used to treat hypertension in adults whose blood pressure is not adequately controlled with any two of these components.
Key Benefits
Combines a calcium channel blocker, an angiotensin II receptor blocker and a thiazide diuretic
Suitable for patients not adequately controlled on dual antihypertensive therapy
Helps lower blood pressure, supporting reduced risk of stroke and heart attack
Once-daily oral dosing
Can be combined with other antihypertensive agents as advised by a physician
How to Use
Take once daily by mouth, swallowing the tablet whole without splitting. The dose may be increased after two weeks if needed, up to a maximum of 10 mg/320 mg/25 mg, as directed by your physician. Not intended as initial therapy.
Active Ingredients
Amlodipine (as besylate), Valsartan, Hydrochlorothiazide.
Precautions
Consult your physician before use if you have kidney or liver disease, are pregnant or breastfeeding, or take other blood pressure medications.
Storage
Store below 30°C in a dry place, away from direct sunlight and out of reach of children.